Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Workday Inc — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while Workday Inc trades at $186.59 (market cap $45.26B). The key difference: Workday Inc is far larger — about 19.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.
| SLS | WDAY | |
|---|---|---|
Market Cap | $2.27B | $45.26B |
Volume | 4,179,659 | 2,342,190 |
Sector | Health | Technology |
52-Week High | $15.46 | $245.67 |
52-Week Low | $1.39 | $112.55 |
Enterprise Value | $2.14B | $45.63B |
Typical Hold Time | — | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Workday (WDAY) trades at $187.81, up 1.93% today, with a neutral technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.75 exceeding the $2.61 forecast. Revenue growth is robust, projected to reach $10.2B in 2026, and the company maintains a high gross profit margin of 75.8%. Recent strategic moves include expansion into the UAE and AI product launches, though layoffs signal operational realignment.
The outlook for WDAY is positive, driven by AI integration and solid financials, but risks include competitive pressures and execution challenges. Analyst consensus is a Buy with a $202.92 price target, suggesting upside potential. Investors should weigh strong profitability against valuation multiples that remain elevated compared to peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
